We are live on ! Find out more
MTIP

Magee Thomson Investment Partners Portfolio holdings

AUM $259M
1-Year Est. Return 34.48%
This Fund
S&P 500
This Quarter Est. Return
+7%
1 Year Est. Return
+34.48%
3 Year Est. Return
+94.32%
5 Year Est. Return
10 Year Est. Return
AUM
$406M
AUM Growth
-$3.49M
Cap. Flow
-$22.6M
Cap. Flow %
-5.56%
Top 10 Hldgs %
43.11%
Holding
171
New
21
Increased
26
Reduced
70
Closed
26

Top Sells

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$16.9M
2
BFH icon
Bread Financial
BFH
+$16.8M
3
JCI icon
Johnson Controls International
JCI
+$11.7M
4
CSGP icon
CoStar Group
CSGP
+$10.8M
5
HXL icon
Hexcel
HXL
+$9.04M

Sector Composition

Rank Sector Weight
1 Healthcare 26.69%
2 Technology 23.8%
3 Communication Services 12.84%
4 Consumer Discretionary 11.71%
5 Industrials 10.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSCD
126
DELISTED
CASCADE MICROTECH, INC.
CSCD
$5K ﹤0.01%
470
+2
+0.4% +$23
MVNR
127
DELISTED
MAVENIR SYS INC COM STK (DE)
MVNR
$5K ﹤0.01%
+469
New +$5.85K
HPJ
128
DELISTED
Highpower International Inc
HPJ
$5K ﹤0.01%
+611
New +$3.38K
MPAA icon
129
Motorcar Parts of America
MPAA
$258M
$4K ﹤0.01%
142
-219
-61% -$5.83K
MXL icon
130
MaxLinear
MXL
$6.8B
$4K ﹤0.01%
+655
New +$5.9K
NGS icon
131
Natural Gas Services Group
NGS
$477M
$4K ﹤0.01%
177
-63
-26% -$1.84K
PXLW icon
132
Pixelworks
PXLW
$41.6M
$4K ﹤0.01%
+47
New +$4.01K
SPNS
133
DELISTED
Sapiens International
SPNS
$4K ﹤0.01%
609
-80
-12% -$623
SDPI
134
DELISTED
Superior Drilling Products Inc.
SDPI
$4K ﹤0.01%
635
-84
-12% -$526
VYNT
135
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$4K ﹤0.01%
3
HSTO
136
DELISTED
Histogen Inc. Common Stock
HSTO
$4K ﹤0.01%
3
+1
+50% +$1.44K
IPHI
137
DELISTED
INPHI CORPORATION
IPHI
$4K ﹤0.01%
297
-324
-52% -$4.71K
STML
138
DELISTED
Stemline Therapeutics, Inc.
STML
$4K ﹤0.01%
260
-35
-12% -$431
GST
139
DELISTED
Gastar Exploration Inc.
GST
$4K ﹤0.01%
677
-90
-12% -$661
ACW
140
DELISTED
Accuride Corp
ACW
$4K ﹤0.01%
1,132
+154
+16% +$734
GIG
141
DELISTED
GigPeak, Inc.
GIG
$4K ﹤0.01%
3,343
-1,485
-31% -$1.92K
BALT
142
DELISTED
BALTIC TRADING LIMITED COMMON STOCK
BALT
$4K ﹤0.01%
758
-44,555
-98% -$242K
HYGS
143
DELISTED
Hydrogenics Corp
HYGS
$4K ﹤0.01%
237
-32
-12% -$654
ATTU
144
DELISTED
Attunity Ltd
ATTU
$4K ﹤0.01%
518
-68
-12% -$496
PQUE
145
DELISTED
PETROQUEST ENERGY INC (DE)
PQUE
$4K ﹤0.01%
634
-84
-12% -$530
ACIC icon
146
American Coastal Insurance
ACIC
$494M
-280
Closed -$4K
BFH icon
147
Bread Financial
BFH
$4.38B
-74,854
Closed -$16.8M
CSGP icon
148
CoStar Group
CSGP
$12.3B
-683,900
Closed -$10.8M
FOCL
149
EDAP TMS S.A.
FOCL
$233M
-1,564
Closed -$8K
HXL icon
150
Hexcel
HXL
$7.82B
-221,000
Closed -$9.04M

Similar funds

Magee Thomson Investment Partners's Q3 2014 Portfolio in Review

As of Q3 2014, Magee Thomson Investment Partners held 171 positions worth $406M, down 0.85% from $409M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Magee Thomson Investment Partners withdrew a net $22.6M in Q3 2014, closing 26 positions and reducing 70 holdings. Its most notable exit was Starbucks, an estimated $16.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 20% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Magee Thomson Investment Partners opened a new position in Tesla worth $10.8M.

  • Magee Thomson Investment Partners's largest Q3 2014 buy was Tesla: 670,050 shares worth $10.8M.
  • Magee Thomson Investment Partners added most to Pacira BioSciences in Q3 2014, an estimated $11.9M increase.
  • Magee Thomson Investment Partners's biggest Q3 2014 reduction was Alexion Pharmaceuticals, cutting an estimated $8.7M.
  • Magee Thomson Investment Partners fully exited Starbucks in Q3 2014, selling an estimated $16.9M.
  • Magee Thomson Investment Partners's ten largest holdings make up 43% of its $406M portfolio in Q3 2014.
  • Magee Thomson Investment Partners opened 21 new positions and closed 26 in Q3 2014.
  • Magee Thomson Investment Partners's portfolio value fell 0.85% quarter-over-quarter to $406M.

Based on Magee Thomson Investment Partners's 13F filing for Q3 2014, filed 5 Nov 2014.